Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,253 | 25,496 | 29,310 | 34,355 | 19,943 |
| Marketable Securities | N/A | N/A | 0 | 0 | 2,480 |
| TOTAL | $20,682 | $26,443 | $30,206 | $35,485 | $23,432 |
| Non-Current Assets | |||||
| PPE Net | 78 | 91 | 102 | 118 | 132 |
| Intangibles | 120 | 120 | 120 | 120 | 120 |
| Other Non-Current Assets | 100 | 100 | 107 | 100 | 100 |
| TOTAL | $298 | $311 | $329 | $338 | $352 |
| Total Assets | $20,980 | $26,754 | $30,535 | $35,823 | $23,784 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,264 | 1,296 | 1,362 | 1,179 | 841 |
| Accrued Expenses | 1,100 | 830 | 475 | 651 | 939 |
| TOTAL | $2,364 | $2,126 | $1,837 | $1,830 | $1,780 |
| Non-Current Liabilities | |||||
| TOTAL | $5 | $12 | $18 | $24 | $29 |
| Total Liabilities | $2,369 | $2,138 | $1,855 | $1,854 | $1,809 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,461 | 7,831 | 7,830 | 7,509 | 7,486 |
| Common Shares | 8 | 1 | 8 | 7 | 4 |
| Retained earnings | -169,298 | -162,363 | -156,870 | -151,084 | -146,304 |
| Other shareholders' equity | -13 | -12 | -10 | -9 | -8 |
| TOTAL | $18,611 | $24,616 | $28,680 | $33,969 | $21,975 |
| Total Liabilities And Equity | $20,980 | $26,754 | $30,535 | $35,823 | $23,784 |